Prescription Weight Loss - Models to meet the demand
Baobab Room
Information
As obesity rises globally and additional disease burdens the population, the boom in popularity of GLP-1 weight loss drugs over the past 18 months has patients, investors and health systems very excited. A swathe of different models from incumbent and new market entrants have popped up combining online subscriptions and digital behavioural, nutrition and fitness support, which so far show great signs of success. This session compares a number of subscription and digital weight loss models on the market, discusses regulation, reimbursement and how to scale up production to meet demand and what the further investment opportunities are for this potentially groundbreaking innovation.
